The Latest in Multiple Sclerosis

MS disease activity returns in one-third after fingolimod withdrawal

November 15, 2018

Multiple Sclerosis

Anti-MOG antibodies associated with non-MS, monophasic demyelinating disease in young children

November 15, 2018

Multiple Sclerosis

Demyelinating diseases, especially MS, disrupt normal brain development in children

November 15, 2018

Multiple Sclerosis

Alemtuzumab switch linked to good MS outcomes

November 14, 2018

Multiple Sclerosis

Vitamin D Levels at Onset Predict Subsequent Cognition in MS

November 7, 2018

Multiple Sclerosis

To Escalate or Not to Escalate MS Therapy After Relapses?

November 7, 2018

Multiple Sclerosis

Low Spinal Cord Volume Associated With Increased MS Disability

November 7, 2018

Multiple Sclerosis

Predicting Disability Following Clinically Isolated Syndrome

November 5, 2018

Multiple Sclerosis

Long-Term Follow-Up of Ocrelizumab-Treated Patient With Relapsing MS

November 5, 2018

Multiple Sclerosis

Ongoing Neuronal Loss Is Greater in Secondary Progressive MS Than Primary Progressive MS

November 5, 2018

Multiple Sclerosis

Vitamin D Augments Glucocorticoid Efficacy

November 5, 2018

Multiple Sclerosis

No Elevated Cancer Risk With MS Therapies in COMBAT-MS Data

November 5, 2018

Multiple Sclerosis

Mood Disorders May Worsen Multiple Sclerosis Disability

November 2, 2018

Multiple Sclerosis

MRI Measure Distinguishes MS From Migraine

November 2, 2018

Multiple Sclerosis

Periventricular Lesions Are Associated With Cortical Thinning in MS

November 2, 2018

Multiple Sclerosis